Benzinga | Jan 20, 2021 07:47AM EST

Edesa Biotech To Join Panel Discussion At Government COVID-19 Event

TORONTO, ON / ACCESSWIRE / January 20, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, announced today that Dr. Par Nijhawan, Chief Executive Officer, is scheduled to participate in a virtual event organized by Clinical Trials Ontario in collaboration with the Bureau du Qu?bec ? Toronto and the Canadian and International Innovation Partnerships Directorate. As part of a government and industry panel, Dr. Nijhawan is expected to discuss the importance of developing multiple countermeasures to the COVID-19 pandemic, including therapies, like Edesa's EB05 drug candidate, that target the overactive host immune response in COVID-19 patients.

The panel discussion, which is titled "Canadian Innovative COVID Solutions," is scheduled to take place on Thursday, January 26, 2021 at 2:20 PM Eastern Time. More information is available at the event website.